NCT07576101 Low Blood Flow Restriction Training on Low Back Pain
| NCT ID | NCT07576101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2026-05-02 |
| Primary Completion | 2027-05-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2026-05-02 with a primary completion date of 2027-05-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled trial is to find the effectiveness of low load blood restriction training on improving hamstring muscle strength, alleviating pain and reducing functional disability in nonspecific low back pain patients
Eligibility Criteria
Inclusion Criteria: Participants falling in this category would be recruited into the study. 1. Both gender 2. Age is between 18-45 years 3. Individuals with pain localized posteriorly below the costal margin and above the inferior gluteal folds for more than 12 weeks 4. A score greater than or equal to 4/10 on Numeric Pain Rating Scale (NPRS) 5. Hamstring muscle strength graded between (3- to 4) on MMT 6. Proximal thigh circumference between (27.0 cm to 56.0 cm), measured 10cm below the inguinal crease 7. Eligible for BFR training as per the Blood Flow Restriction Blood Flow Training Questionnaire Exclusion Criteria: Participants falling in this category would be excluded from the study. 1. Patients of spinal stenosis, disc herniation spondylolisthesis, spondylosis or osteoporosis will be excluded 2. Participants had a history of hip or lower extremity pathology requiring medical or surgical intervention. 3. History of venous thromboembolism (VTE), clotting or other hematologic disorder 4. Peripheral arterial disease, hypertension (blood pressure \>140/90 mm Hg), coronary artery disease 5. Current Pregnancy 6. Patients who had difficulties in exercise performance due to mental problems. 7. Spinal cord infection like Cauda equina syndrome
Contact & Investigator
KINZA ANWAR, MS-OMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576101 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576101 currently recruiting?
Yes, NCT07576101 is actively recruiting participants. Contact the research team at kinza.anwar@riphah.edu.pk for enrollment information.
Where is the NCT07576101 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07576101 clinical trial?
NCT07576101 is sponsored by Riphah International University. The principal investigator is KINZA ANWAR, MS-OMPT at Riphah International University. The trial plans to enroll 44 participants.